Charles Schwab Investment Management Inc. Raises Stock Holdings in Rentokil Initial plc (NYSE:RTO)

Charles Schwab Investment Management Inc. raised its position in shares of Rentokil Initial plc (NYSE:RTOFree Report) by 70.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 34,866 shares of the company’s stock after buying an additional 14,389 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Rentokil Initial were worth $883,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Cape Investment Advisory Inc. lifted its position in Rentokil Initial by 65.2% during the 4th quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company’s stock valued at $38,000 after acquiring an additional 594 shares during the period. Sunbelt Securities Inc. boosted its position in shares of Rentokil Initial by 30.1% in the 3rd quarter. Sunbelt Securities Inc. now owns 1,737 shares of the company’s stock worth $43,000 after purchasing an additional 402 shares in the last quarter. CENTRAL TRUST Co grew its stake in shares of Rentokil Initial by 15,208.3% in the 4th quarter. CENTRAL TRUST Co now owns 1,837 shares of the company’s stock worth $47,000 after buying an additional 1,825 shares during the last quarter. Smartleaf Asset Management LLC increased its position in Rentokil Initial by 486.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,942 shares of the company’s stock valued at $49,000 after buying an additional 1,611 shares in the last quarter. Finally, Cromwell Holdings LLC purchased a new position in Rentokil Initial during the fourth quarter valued at $59,000. Institutional investors own 9.91% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on RTO shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Rentokil Initial in a research note on Friday, March 7th. Citigroup raised shares of Rentokil Initial to a “strong-buy” rating in a research report on Friday, December 13th. Four investment analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

View Our Latest Research Report on RTO

Rentokil Initial Price Performance

NYSE RTO opened at $22.92 on Monday. The company has a 50-day moving average price of $24.20 and a 200-day moving average price of $24.81. Rentokil Initial plc has a 52 week low of $20.60 and a 52 week high of $34.07. The company has a quick ratio of 0.96, a current ratio of 1.04 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $11.57 billion, a P/E ratio of 15.18, a PEG ratio of 7.95 and a beta of 1.14.

Rentokil Initial Dividend Announcement

The company also recently announced a semi-annual dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 4th will be issued a $0.3825 dividend. This represents a yield of 2.4%. The ex-dividend date is Friday, April 4th. Rentokil Initial’s dividend payout ratio is 43.71%.

About Rentokil Initial

(Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Further Reading

Want to see what other hedge funds are holding RTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rentokil Initial plc (NYSE:RTOFree Report).

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.